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Pmel17 is preferentially expressed in pigment cells in 
a tnanner suggestive of involvenlent in melanin bio-
synthesis. The gene is identical to the silvey (si) pig-
tnentation locus in mice. We now have produced a 
recombinant glutathione-S-transferase-human Pmel 
17 fusion protein and raised polyclonal antibodies 
against it to confinn the ultrastructural location and 
presumed site of action predicted by the deduced 
primary structure of Pmel 17/ silveY, and to authenti-
cate the specificity of the DHICA converting func-
tion as inherent to the silvey-locus protein. Full-
length Pmel 17 eDNA also was produced in insect 
cells in a baculovirus expression vector to ensure that 
activity did not originate from a co-precipitated pro-
tein. Natural hPmel 17 from human melanoma cells 
has an approxintate tnolecular size of 100 kDa. By 
itnmunoperoxidase electron microscopic cytochem-
P //lei 17, originaUy isolated from a human foreskin melanocyte Agtll cDNA expression Ijbrary, is spc-citicaUy produced in melanocytes and maps near the sillier coa t color locus on mouse chromosome 10 and to region q12- q13 on human chromosome 12 (Kwon 
et ai, 1991).' [n normaJ human melanocytes, Pmcl17 mRNA levels 
correlate with melanin content better than does expression of 
tyrosinase, the key enzyme of m e lanogenesis, suggesting that the 
silver protein functions as a positive regulator of melanin biosyn-
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istry, the antigen was localized to the limiting mem-
branes of pretnelanosomes and presumed premelano-
genic cytosolic vesicles and, to a minor extent, in the 
premelanosomal matrix. In an ill vityo assay, both the 
natural and the recombinant Pmel 17 accelerated the 
conversion of DHICA to melanin. This activity was 
inhibited by the anti-Pmel 17 polyclonal antibodies, 
indicating that the acceleration of DHICA conver-
sion by the natural protein is genuine and cannot be 
due to contaminating complexed proteins. We sug-
gest that ill situ Pluel 17/silvev is a component of a 
postulated premelallosomal/melanosomal complex 
of melubrane-bound melanogenic oxidoreductive en-
zymes and cofactors, in analogy to the electron transfer 
chain in ntitochondria. KI!J' woyds: melalloma a II tige 11/ 
",elallocyte/tyl'osirlase-yelated p,'oteills/NK1-beleblHMB 45. 
] l,west Devmalo1106:605-610, 1996 
thesis distal to tyrosinase (Kwon et nl, 1987). Like tyrosinase Pmel 
17 tnRNA expression, in murine Cloudman S-91 and human 
melanotic melanoma ceUs is induced by agents that inc rease 
melanization (Kwon et nl, 1987). On the basis of sequence homol-
ogy, we have proposed that at least two gene families regulate 
m e lanin biosynthesis (Kwon, 1993) : the cyrosinase gene family, 
whjch includes tyrosinase, TRP1/gp75, and DOPAchrome tau-
tomerase or TRP2; and the Pmel 17 gen e family , wluch includes 
Pmel 17/gp100 (see below) of mammalian melanocytes, MMp115, 
a chick en melanosomal matrix prote in (Mochii el ai, 1991), and 
Rl'E1, a bovine retinal pigment epithe ljal protein homologous to 
Pmel 17 (Kjm and Wistow, 1992). In its general structure, Pmel 17 
is similar to tyrosinase, TRPl, and TRP2 inasmuch as it possesses a 
putative transmembrane domain and a cytosolic tail (Kwon et ai, 
1991); its amino acid sequence is similar to that of MMp115, with 
the exception that the latte r has no putative tnU1smembrane 
domajn. 
R ecently, we demonstrated that PIliI'I 17 from si lsi nuce contains 
an (A) insertional mutation in the putative cytosolic tail, indicating 
that Pmel17 protein is indeed the product of the sillier locus (Kwon 
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ct aI , 199 4; Kwon et aI, 1995) . StiU in question , however , are the 
precise subcellular loc ation and fun c tio n of Pm e l 17 . 
MATERIALS AND METHODS 
Production of HUlnan Ptnel 17 in Bacteria and Insect Cells For 
expressio n in bac teria , a midportio l1 o f human Pmcl 17 cDNA encoding 
amino acids 141-435, spanning the re pe ti tio n m o tif (Kwo n ci aI, 1. 991) , was 
fu sed in fr ame with the glutathio ne-S-transferase (GST ) gene using the 
pGEX vector (Pharmacia, Piscataway, NJ) . The fusio n protc in GST -human 
Pm el 17 , expressed in Esell erirhifl coli strain T op 1 (Stratagene, La Jolla. CAl , 
w as purified by all-ini ty chromatograph y over glutathione beads and used to 
raise polyclo nal anti-Pmel! 7 antibodies (sec below). 
A bacu!o virus express io n vecto r containing the full-size hPmcl 17 was 
constructed fo r production o f a full-l ength rhPmel 17 in no nmelanogenic 
insect cells exprcssing no o the r melanogenic pro tein . A 2 .0-kb EcoR 1 
fragmen t of hPmcl 17 cDNA encoding the complete protein was inserted 
into the EcoR1 site o f the PVL 1393 vecto r (a gift fro m Dr. Max Summers, 
Tex<l s A&M University) . T he Pmel 17 cDNA was transferred fi'om the PVL 
1393- hPmel J 7 pl as mid to the AcNPV (A lliogral'ha cnlij" ,.,,;a nuclear po ly-
hedrosis baculovirus) by co transfecting bo th plasmid and virus into 5if-21 
(Spadoplcra ./i·IIg;pcrda-21) insect cell s (a gift from D r. Max Summers, Texas 
A&M Unive rsity) , as described (Miller et 01, 1986). Ten occlusion-negative 
AcNPV-hPm el 17 viral plaques were isola ted and grown as stocks in Sf- 21 
ce lls in serum-free Ex-C ell 400 m edium (J1U-I Biosciences, Lenexa, KS). 
T he hPmel 17 iml11unopurified from insect ce ll s w as used in fun ctional 
studies. 
Preparation of Rabbit Polyclonal Antibodies and Affinity Purifica-
tion o f Natural and Recombinant Fortns of HUJnan Pmel 17 
GST -hPmel 17 fusi on protein (100 [.1g) in 0.5 m l Ti ter- Max (CytRx, 
No rcross, G A) ; .• djuvant was injected intraderll1ally in to each of two rabbits, 
fo ll ow ed by a second dose 4 weeks later . A booste r (500 [.1g in 0. 5 ml 
phosphate-buffered saline) was gi ve n witho ut adjuvant through an car vein 
4 weeks after the second immuniza ti o n . Afte r a 10-day waiting period , the 
rabbi ts were bled , and the IgG fra cti o n was purjfied o n a pro te in A affinity 
column and stored 'at - 70°C . These antibodies w ere used in immun opuri-
fi cati o nst w es te rn iI11I11Ul1 o blo tting, and illlnlulloc icctro n 111 ic roscopy. 
YU SITl melano m a cell s, 1 X 10" cells/batch, w ere lysed in a buffer 
containing 50 mM T ri s H C /. pH 7. 6, 300 mM CaCI" 0.5% Tri ton X-l 00, 
and 10 [.1g/ml each o f pro teinase inhibito rs chym os tatin (Boehringer, 
Mannhc im , Germany) , pepsta ti n , Icupeptin , and apro tinin (Sigma C hemical 
Co ., St. Loui s, M O ) . SF 21 cell s, infected w ith AcNPV-Plll cl 17 at 0. 5 
m.o.i. (multiplicity of infection) during a 3-day cxposure, we re harvested 
and resuspended in a lysis buffer containing 0 .1 M sodium phospha te, pH 
6.8, plus 10 [.1g/ml o f each of the abo ve inhibito rs. 
Ex tracts fro m both cell types were centrifuged at 10,000g for 10 min 
before being subjected to immunoall-inity purification . Toward thi s end , 
an ti-Pmel 17 antibodies we re conjugated to Affi-Ge l H z-hydra z ide ge l 
(Bio-Rod poly-prep column; Bio .. Rad , IliclU1lOnd, C Al according to the 
111anufac ture r' s instruc ti o ns. Plllei 17 w as purifi ed fro ln th e 1l1c lan0 l113 and 
insec t cell Iysates employing the Immuno pure An tigen/Antibody bufte r 
system kit (Pierce, R.ockford, IL) according to the manufacturer' s instruc-
tio ns. Brie fly, the supernatants we re applied to the columns ; no nspecificall y 
bo und proteins were removed by exhaustive washing; and specific-binding 
prote ins were eluted with low-pH elution buft'er as instructed. Elu ted 
protein solu tions we re ne utralized immediately to pH 7.5 w ith 1 .5 M Tris 
H C I, pH B.8, and stored at 4°C. 
Western 1.nmunoblotting T wo human melanoma ce ll lin es, YU SIT 1 
and OCM-1 , and two nonmelanocyti c cell lines, I-le La ce ll s and T HP-1 
monocytes (ATCC , CCLl , 'Illd ATCC TIB202) , we re used as positive and 
negative contro ls for Pmel 17 , respectivel y. T he ce ll s were washed i,l 
phosphate-buft'ered sali ne and lysed for 15 min in icc- cold bufFer consisting 
0[50 mM Tris I-IC I, pH B.O, 1'1., Nonide t 1'-40, and 1 mM ethy lenediamine 
tetra-"cetic acid plus the proteinase inhibitors aprotinin , leupeptin , an.d 
pepstatin at 10 [.1g/ml each. Lysa te, we re centrifuged at 1 O,o'OOg for 10 min 
at 4°C . The superna tants , contain ing approx imate ly 1 [.1g o f pro tein / p.l, 
we re denatured by bo iling fo r 2 min in sample buft'er. 
Cell extracts (10 [.1g prote in/ lane), or fra ctions fro m anti-Pmcl-17 
immunoaftin.i ty columllS, were subjec ted to sodium dodecylsulfate (10%)/ 
po lyacrylamide gel electropho resis, transferred o nto Immobilon-p mem-
branes (Millipore Corp. , Bedford , MA) , and incuba ted with thc po lyclonal 
rabbi t anti-Pmel 17 antibodies (1: 5,000 dilutio n), follo wed by alkaline 
phosphatase- conjugated goat anti-rabbit antibodies and phosphatase chro-
mogenic substrate, according to the manufacturer' s instructions (Bio-Rad). 
lmmunoperoxidase Electron Microscopy The po lyclo nal antibodies 
were used at a dilution of l :250 in the subcellu lar localizatio n o fhPm el 17 
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Figure 1. Western immunoblots ofhPmcl17/100-kDa protein. Lalle 
I, who le-cell lysa te of YU SIT 1 m etastatic melano m,.; InI,e 2, immunoaf-
fini ey-purified Pmel 17 (1 ng prote in) fi 'om YU SIT I lysa te ; lalle 3, 
who le-cell lysate of OCM-1 ncular m elanoma ; lalles 4 and 5, whole-cell 
Iysates of no nmelanocytic control cell lines T HP-l and H e La. Whole-cell 
Iysates were applied at 10 [.1g pro tein/ lane . 
antigen . Amelanotic m elanocytes from a tyrosmase-posltlve adult humau 
albino were grow n in melanocyte m ediulTl as desc ribed (Halaban dol. 
1988) . Mono layers were fi xed ;11 s;rll in a co ld mix ture o f 1'1., parafo[mal-
dehyde and 0 .5% glu taraldehyde in O. l M sodium cacodyla te buffer (PH 
7.2). During subsequent washing (5 min), ullfcacted aldehyde was neutral-
ized with 0 .1 % glycine i.n phosphate-bufrc red sa line . C dl s were then 
pe rI11 eabili zed with 0. 02'}'u T ri to n X-l 00 CI min) , and no nspeci fic binding 
sites we re blocked wi th comm crcial serum (a.nti-rabbit VeelaslI';1I A BC kit; 
Vecto r Laboratories . Burlingame, C Al (30 min). The remaining steps of the 
immun ocytochemica l procedure were according to the Verlaslai" iml11uno-
pc ro x;da sc ki t instructi o ns. In the ho pe o f se lec ti ve ly inactivating intrinsic 
catalase (pe roxidase), W I! exposed sO llle preparations bri eRy [0 0. 03'y" H2 0 , 
be fo rc incubating (hl!m with the anti-Pmel 17 antibodies. Uefo re dehydra-
ti on and cmbedding in Epo xy resin , the cell s were re fixed with cacodylate-
hutfered 3'y" glutaraldehyde , foll owed by a mixture o f bufI'cred 1 % O sO, 1 
1.5% po tass ium ferrocyanide fo r contrast. Ul tra thin sections, cut in a plaJle 
parallel to the culture surface , were counte rstained with lead fo r further 
contrast and viewed in a ZEISS EM 109 transmiss io n e lectron microscope. 
DHICA Conversion Assay T he DHI C A conversio n assay was per-
fo rmed as fo llo ws. R eaction mixtures (final volume 550 [.11) consisted ofl00 
[.11 a ll-Ini ty-purified hPmei 17 o r rh Pmel 17 (0.1 [.1g/ml) , 5 [.11 anti-Pmel 17 
IgG (10 [.1g/ [.11) where applicable , 350 [.11 bufI'e r containin g 0 .1 M sodium 
phospha te and 0 .1 111M phenylthiourea, 1'1-1 7 .0 , plus 100 [.11 o f 0.5 m M 
DHI CA (a gift fro m Drs. Ashok C hakn.bo rty and J o lm Pawelek, Yale 
Uni versity). T he mix tu res we re incubated at 37°C fo r various periods of 
time . at the end o f which the optical density shift due to m elanin formation 
was measured in a Beckman DU-64 spectro photonH!tcr set at optical dens.ity 
400 nm. 
R E SULTS 
Size of Human PmcI 17 W e had shown pre vio u sly that th e 
hPme l 17 gene was e x pressed pre fe re ntially in pig ment cells . T h e 
amino ac id backbone d c duced ITo m th e clon e d eDNA wa s 68. 6 
kD a. fn th e present study , e xpression and molecu lar size wcre 
dete rmin ed by Western immunoblotting (Fig 1). Pm e l17 appeared 
as a pproA;mate ly a tOO-kDa pro te in in whole- cell Iysa tes fi:0 111 two 
human melanoma cell line s and in seve ral imJ11unoaffinity-purified 
fra c tions. The higher apparen t molec ular w e ig ht o f the nati v€.' 
protein can b e attribute d to glycosylation . Th e recombinan t hPmei 
17 prote in e xpressed ill insect cells w as some what small e r than the 
l11<lJnl11a li an pig ment cell produc t (data n o t shown). N o Pl11 e l 17 
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was detected in nonpigment ce ll s, such as !-leLa cells or THP-l 
monocytes . Some aitinity-purified fractions were resolved as two 
reactive bands: the 100-kDa b;lI1d and another of 52 kDa (data not 
shown). T he smaller protein could represent a degradation product 
of Pmel :17, but more like ly is anti-Pmel 17 JgG heavy chain leached 
from the column . 
Subcellular Localization of Hun~an PInel 17 The abundant 
distribution of Pmel 17 gene product in human m e lanocytes is 
illust ra ted in Fig 2 . We used tyrosinase-positive albino meh1l10cytes 
to avoid interferen ce by melanin with both the accuracy of 
localization and the clarity of visualization of thc immunoperoxi-
dase reaction product. The ul trastructure of the amelanotic mela-
nocytes in a control preparation that was incu bated without the 
primary antibodies is shown in Fig 2a. T h e cell s contaill ed 
well-fon11ed premelanosomes of the e um elanosome type, with 
l.irrtiting membranes devoid of peroxidatic rea ction product 01' 
melanin . T he myriad sma ll e lectron-de nse cytoplasm ic vesicles may 
be microperoxisomes, with peroxidase activity due to catalase 
(Novikoff el aI, ] 973). Vesicles of the same size in controls not 
incubated for peroxidase activity were devoid of such contrast (not 
illustmted). Somc of the micropel'oxidatic vesicles had been inter-
nalized by premelanosomes or were present in multivesicul ate 
bodies. 
Bound polyclonal ;l11ti-Pmel 17 antibodies, on the oth er hand 
(Fig 2b), were localized to the limiting membranes of the (pre-) 
melanosomes and to cytoplasmic vesicles, many of which were of 
the coated va l'iety and large r than the presumed microperoxisomes. 
T he unreactive membranes of mitochondria and endoplasmic re-
ticul um served as built-in contro ls . 
The reaction prod uct was located at th e inte rnal surf.1ce of the 
(pre)melanosomal and vesicular membranes (Fig 2c), consiste n t 
with an ep itope or epitopes along the N-terminal extracytosolic 
extension of Fmel ] 7, which contain s the presumptive g lycosyla-
tion sites. Aga in , a few (pre)melaJlosomes also contained reaction 
product in the form of g lobules within the matrix. Preincubation 
wi th H 2 0 2 , in an attempt to inhibit selective ly native cata lase, 
markedly diminished antibody binding but unde rscored the mem-
brane and matrix-globular localizatio ns (Fig 2d) . 
DHICA Converting Activity of Pmel 17 Because Pmel 17 
fro m pigment cells may be complexed w ith other melanogenic 
proteins (Orlow el aI, 1994) and during immunopurification may 
tag along tyros in ase, TR.P1, and TRP2, and perhaps others not yet 
known, recombinant hPme l 17 expressed in the no n melanogenic 
Sf-21 insect cells was immunopurified and tested for DHICA-to-
melanin converting 'lctivity. In contrast to parenta l cells or cells 
infected with an irre levant recombinant baculovirus, the iJllmUnO-
purified baculovirus-ex"jJressed Pmel 17 tested positive (Fig 3a). 
This activity was protein dose dependent. Furthermore, fractions 
containing immunoaffinity-purifi ed native hPmcl 17, as identifi ed 
by we tern blot analysis (Fig 1), were pooled and assayed for 
DHTCA-to-melanin converting activity in the presence and absen ce 
of anti-Pmel 17 antibodies. The DHICA converting activity was 
blocked by the antibodies (Fig 3b) . 
DISCUSSION 
We h ave shown that human Pmcl J 7 I sililcr, a protein of 100 kDa, 
is located in vesicular and (pre)mclanosom;ll limiting m embranes 
and that ill Ililro , this protein accelerates th e conversion of DHICA 
to melanin. T he enzymatic activity was detected in immunopre-
cipitates of melanoma cell extracts using polyclonal anti-Pmel 17 
anti bod ies and in recombinant Pmel 17 produced in nonmelano-
genic insect cells. T he latter ensured that the DHICA conversion 
activity did not originate from a co-precipitated melanogenic 
protein. Our data complement those of C hakra borty el al, 2 who 
reported superoxide-dependent polymerization of DHICA in the 
2 Chakra borty AK, Platt JT, Kim K-K, Kwon 135, Bennett DC, Pawelek 
JM: Polymctization of 5,6-dihydroxyindolc-2-carboxylic acid to melanin by 
the Pmel 171s il ver loc lI s prote in . Ellropenll J Bioc!tclII. 1996 . ill press. 
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presence of immunopurified native Pmel ] 7. Because it facili tates 
the formation of melanin and is located in the limiting membranes 
of known melanogenic subcellular organ elles, Pmel 17 may be a 
constituent of a postulated membrane-bound melrulogenic complex 
of oxidoreductive enzymes (Orlow el ai, 1994) that include tyrosi-
nase (A/billo or c- locus protein) and the tyrosinase-related proteins 
TIU~l (gp7SIIJ-locus protein Oacksol1, 1988; Halaban ruld Moell-
m~nn, 1990; Tomita ci al. 1991]) and TRP2 (DOPAchrome 
tautomerasel slaty- locus protein [Krompo uzos et ai, 1994]), in anal-
ogy to the electron transfer chain in mi tochondria. 3 Matrix com-
ponents bound the an ti -hPme l 17 antibodies in a distribution 
consistent with vesiculog lobul ar bodies Oimbow and Fitzpatrick, 
1994). 
T he m embrane localizations confi rm predictions based on the 
deduced ruluno acid sequence of Pmel ] 7 (Kwon el aI, 1991). This 
sequence calls for a glycoprotein with a tra nsmembrane domain and 
a cytosoli c tai l, with the majority of the g lycosylated chain extend-
ing in to an extracytosolic space, such as a vesicular lumen (e.g., 
m e lanosome), or, in the case of vesicular exocytosis, an extracel-
lular space where the protein may become antigenic. In f.1Ct, a 
protein analogous to Pmel 17, referred to as gpl00 (Adem a el ai, 
1994) and recognized by m onoclona l ;l11tibodies NK] I beteb, 
HMB-45, and HMB-50 (Schaumburg-Lever et ai, 1991; Adema el 
aI, 1993; Taatjes ct aI, 1993) , has been identified as a potent 
tumor-derived antigen in m elanoma patients of the human leuko-
cyte antigen-A2 haplotype (Cox el ai, 1994; K awakami el ai, 1994). 
Pme l 17 and gplOO are translation products of alte rnatively spliced 
mRNA (Adema el ai, 1994) . T h e membrane loca lization ofPmel1 7 
agrees w ith the binding sites ofNKl/beteb (Winder el al. 1994). an 
antibody raised against a membrane preparation from a human 
m etastatic melanoma (Vennegoor ci ai, 1988), and with the immu-
nogold data obtained with rabbit polyclonal antibodies raised 
against a m elanosomal fraction from murine B16 melanoma cells 
(Orlow cl al. 1993 b; Z hou et aI, 1994). T h e antigenic sites were 
loca lized to the extracytosolic domain of th e membranes, consistent 
with an epitope on the postulated intramelaJlosom aJ glycosylated 
N-terminal extension of Pmel 17. In all cases, the otientation was 
identica l to one obta ined with anti-PEP2, an antiserum specific for 
the predicted luminal portion of the melanosomaJ membrane 
protein TRP1 (Orlow el aI, 1993). Our data , as supported by others, 
including the immunogold data of Orlow ci al (1993b), are 
consistent with the sillier-l ocus product being a I)() II a fide membrane 
protein . 
T he impo rtan ce ofPmel 17 to pigmentation is indicated from the 
ch an ges in melanocyte survival in mice carrying the silsi (sillier) 
mutation (Quevedo el aI, ] 98 ]) . T he sing le nucleotide insertion is 
expected to alter the last 24 amino acids of the original C-terminus 
and length e n the prote in by 12 residues. T h ese changes are likely to 
misguide the mutant protein away from melanogenic membra~les 
because they bring about the loss of a melanosomaJ targetmg 
sequence located in th e C- tenninal extension ofPmei 17 and other 
melanogeluc membrane protein s (Vijayasaradh.i el aI, 1995). T he 
premature death of follicular melanocytes in the sillIer mice sugges~s 
that Pmel-17-accelerated conversion of DHICA to melruun IS 
required for th e speedy removal of cytotoxic in termediates derivir~g 
fro m ea rlier oxidation-reduction reactions in the melanoge111c 
pathway. Gen etic support for this notion comes from the observa-
tion that in Ago/./li lsihw · and in Agolllilyel/ol" lsil,,(~r mice, si lve ring 
d ecreases rather than increases with age (Si.lvers , ] 979) . AgOlIl1 and 
Agollii/yel/olli mice sufi:er .fi·om a mutation that results in a blockade 
of the melan ocytic receptor for melanocyte-stimulating hormone 
(melanotropin) (Lu et ai, 1994) , thereby decreasing expression of 
tyros inase (Halaban el aI, 1984) and Pmel 17 (Kwon et aI, 1987). It 
is reasonable to postulate that in the above mutants, with a 
constitutiona l decrease in eumelanogenic cytotox;c intermediates, a 
J As suggested by Moellm3nn , XIV International Pigmcnt Cell Confe r-
"net:. Kobe, J apa n , 199(). 
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Figure 3. Facilitation of conversion of 5,6-dihydroxyindole-2-car-
boxylic acid (DHICA) into soluble melanin by recombinant as weU 
as native human Pmel 17. a) DHICA converting activity of immunopu-
rified recombinant human Pmel 17 (rhPmel 17; 0 ). whose synches is was 
directed by a recombinanc baculovirus in SJ~2 1 insect ceUs; idc ntica l 
co lumns and procedures were used with control wi ld-type virus-infec ted 
Sf-21 cells (0 ) and ,'if-2 1 cells infected with an unrelated recombinant 
baculoviru s (.). Dinl/w"ds. buffer alone . b) DH ICA converting activity in 
il11m ullopurified nati ve hPmcl 17 from YU SITl melanoma cells . • . hPmel 
17; .0 hl'mel1 7 plus anti -hPmel 17 antibodies: 6 , buller alone. Concen-
trations as in Mnterin ls tII/(1 Metlwds. Each poin t represents mea n ::': SD. 
superimposed sillIer mutation IS not as m elanocytotox ic as in 
eume lanotic, wi ld-type mice. 
The sillier mutatio n has long been known to afFect coat color 
d ilution, 1110st noticea bl y when expressed o n a Bi b (genetic locu s 
encoding TR.]>1) background (Silvers, 1979). Pmel 17 l11ay, indeed , 
complement most strongly w ith TL~P'l, the l11 e lanosoma l O1el11-
brane protein that appears to have bo th DH ICA synthetic activity 
(dopachrome tautome rase [Winder cl ai, '1993, 1994]) and its own 
DHICA conve rtin g ac tivity (DI-IICA oxidase 1J0hnso n and Ja ck-
son, 1992;Jimcnez-Cervantes cl ai, 1994; Kobayashi e/ al. 1994]), as 
well as be ing associated with cata lase activity (I-Ialaban and Moe ll-
mann, 1990). The genetically dominant mouse TRPI muwtion 
Light (B I ,) causes premature m elanocyte deatJl in a ph enotypi c 
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pattern similar to that in si l si mice (Queved o cl ai, 1981). The Bit 
mutation consists of a single amino acid substitution near the 
N-terminus ofTRP1, close to the putative signal-peptide cleavage 
site Oohnson and Jackson, 1992), and may adversely affect the 
insertion of the n ascent protein into the endoplasmi c reticulum , and 
hence melanosom es. The gene tic evidence that two l11 e lanosol11al 
proteins, which for diffe rent reasons may have diffi culty entering 
premelanosomes, produce similar phenotypes strengthe n s the con-
clusion that both have similar functions. N evertheless , the r elative 
importan ce of Pmel 17 is unde rscored by tJle findings of Quevedo 
and Chase (1958), who showed that tJlrough repetitive induction of 
the hair cycl e by plucking and replu cking , the follicular m e lanocyte 
population is rapidly de ple ted in silsi but not BII I BII mice. 
Extrapolating from what is known about the murine sil lier locu s, 
we suggest that human Pmci 17 may have a role in early graying 
and lor postnatally acq uired white spotting (vitiligo), conditions in 
which m e lanocytes die. A search tor a Pmel 17 mutation , not 
necessarily identi cal to that in the si lver m o use, m ay be indicated in 
afflicted individuals. 
Tl,is /Vork /Vas slIppo'led b), U llited S intes Pllblic H eal", Se,."ice Gr(//lls ROt 
A R4024 8 to BSK, ROt A I226 JO to MF, nlld A R J9848 to RH; m,d till, Skill 
Diseases Researel, Cellter Grnllt A R41942 /C) RE T igelanr, Yn le Skill Discnscs 
R cscnrc/, Ce'ller (E K , GM, RH). We tlmllk Dr, Max S 'IIIIII,ers, Texns A&M 
Ulli,'crsi')" jiJr p"ollidillg lire PilL 1393 IIector nlld tlr" SJ:2 J illSecl cells, nlld Drs. 
AsllOk C lmkrabOll), alld JOIrIl PnI/,c/ck , Ynle UlliIJw'il)" for DHICA nlld ,lre 
protorol.fl,r tl,e DHICA colIl'crsioll nssn)' . ' fie gml,j idl), n[kllOldellg" tire tec/Illiml! 
selTetnrinl nssistO/,re of Mr. Riclmrd T. Pick(//'d, Ms. S IISil lI Eicldllllrz, Dr. Yllsltnll.~ 
Xie, nlld Ms. A lldrey C OI"SOIl. nil 4 IIIdinrm Ullillersit)'; nlld Mr. Jark ScI""'iber of 
Ynll' U"illersi,y. 
R E FERENCES 
Adcl1w GJ. de Uocr AJ. va ll 't l-Iullc llIIar R. Dcnijll M. Rui ter DJ . VogcJ AM. ,Figd.o r 
CG: Md;lII ocytc lineage-specific :1 llt"i gC Il S recogni zed hy mo noclomd antibodies 
NK I-bercb. HMU-50. :lIld HMI3-45 arc cncoded by a single eDNA . A lii) POlh,,1 
1~ 3 :1 579- 1 5HS . 1993 
Ade l1l;} CJ . dc Uocr AJ . Vogc l AM. Loell e ll \ X/ A. Figdo r CG: Mo lecular ch:tr3cl,criza-
ti01 1 o f the me lanocyte lin eagc-spccitit: antige 'l g-p I 00 . .1 Bioi Chi'lll 269:20 126 -
20133. 1994 
Cox AL. Skippe r J. C hcll Y. Hende rson R. Darrow T. Sll:IbanowitzJ. Engelhard V. 
Hunt D, Sling-luff" C: Iden tifi c:tli OIl of a peptide recognizcd by five mc lano m .t-
specifi c cyto tox ic T cell lines. Science 264 :7 16-7 18. 1994 
I-Ialahan R . Lnll gdo ll R • .Birchall N. C UOIl O C . Baird A. ScOlt G. Moc lll1l :1I11l G. 
McG uire J: U;lsic fihro b last g row th (;\ctor ofker;\tillocytcS is ;1 11<1 ru rOl l mitogen for 
norl11all11c1anocytcs.j Cdl BiI,1 107: 1611-1(, 19. 198R 
Hal aba ll R . Moellmanll G ; Murine and hum a n I,- Iocus pi gmclwttion gcncs encode a 
g lycopro lc in (gp7S) with cat;!l:lsc activity. Pr"r NlJll l iI"mf S'r; USA 87:48(1)-.18 13. 
1990 
I-Ialaban ll. Po m erantz S I-I, Marshall S. Lerner AB: T YI'osin;1sc :lcriviry an d abund:II H.·c 
ill C loudm :ln m cla l1 01nn cells . .'1 '1'11 [ji()r/I('III B;opl,)),( 23 0:383-387. 198 -1 . 
.Jackso n I.J: A e DNA encod ing: tyrosilt:lse-re hucd protein nt:lpS to rhe browlt loctls til 
m o use Ipu blished c r r;ltU Hl. J'f(I( N atl Arlld Sci US; I B6:997 . 1995 I· Pror N a,1 A ~'ad 
Sri USA 8S: 'l3 n-43%. I 'IH8 
Jilltbow K. Fitz patrick TB: C h:tr:tL"lcriz:lti (Ht Of:l11 CW l1t Cl:tlt Osol1lai srnu.: t~lra l COl1lpO-
n c nt- t1tc vcsic uloglo bular Illldy- hy Cot lVc lttio n a l tr:U1Sllliss io n. Iltg h-vo lmge . 
and scannin g e lectro n mi croscopy . .1 Ultmsll1lrt UI'S 4R: 261)-~83 . 1974 
.Jimcttcz-Ccrv:1I1tcs C. Solano F. f{ o h;, yO\ shi T. U rahc K. Hcarlng ~'J . Lozano J A. 
G:trci a- l3orrb n J C: A ne w e ll zVlIla t ic 1i.1IlCtiOll ill lht! I11 c lallog:c lIIC p:tdtway: rh e 
5.6-d ih ydroxyindo le-2-carbox)dic acid oxidase ac(ivil'Y ofryrosinasc-rc latcd pro-
'"c;I1-1 (TR!'I).) BioI C iI .. ", 2 ('~: 1 7~93- I RO(J1. 1 99~ 
Figurc 2. Subcellular localization of hPnlcl 17 protein to premelanosOlnal and prcsulnptivc prcll1clanogcnic vesicular membranes. A. 
control incubation (anti-PmcI17 antibodics oll1itted). T he pre l11 elanoso l11cs and their limitin g mcmbranes arc devoid of inllll""opcroxidase reaction product 
(cxal11p le between lm:,!c arrollls). The In yriad srnall elec tron- dense vesicles l11ay b e 111i cropc r~xisolllCS containin g: native perox idati c acti v ity. du e to cara la.sc. 
So nIc of these vesicles have b een illtcl'naiiz cd by prcnlcial1oS0 1l1~ S (sma ll ( 11,."t~d atT(JIIJS) and Inultivesicular bodies (swtl ll c",.,,,:d nn·lIf/!s ). B. lInnll1~l O rea~tlv c 
prepara tion. Allti-Pmcl 17-inllnullopcrox idase product outlincs the lillli ting membranes of premclanosornes (I"':~l ' nn''''''s) and prclncl ,mogelllc veSIcles 
(cxanlplcs at n".'!"1tll' arrows). The latter a rc large r th"111 th e. preSt1l11ed mic ro pcrox isol11CS. III; , Illitocho l1dri a: 1111 , nuc.:! e:lr I11 c nlbrill~l e , C. detail frol11 
immunoreactive preparation B. The 'mti-Pmcl-17 immunopcroxida sc product is found on t.he extracytoplasmic (intcrnal) surf;,cc 0 1 (p re)mclanosomal 
limiting 111CI11branes and on thc nlelnbranes o f prcslIl1wd pretllcianogcni c vesicl es (OpCII an'I'/I)s) . Sontc of the reactive prcrnclanosomcs. have p.cr~xldasc­
po ;tive ves icles within thcir matrix (sIIInll (/I,."ed IIIT'''"S); others appear as being approached by cytoso lic vesicles (I",:~c b,.", OIm",s). D . antIbody btndmg was 
diminished by preincubation of thc cc ll s with H20, (to inactivate intrinsic peroxidase due to ca ta lase) , but the loca lization of anti-Pmel 17 to 
(prc) 111 c lanoso lllal IlI c lnbrancs and vcsi culogloblilar b od it.:s pe rsisted . Settle bflrs , U.S J-Lillo 
610 LEE ET AL 
joJulSon R, Jackson Jj: Li.,.\'ltt is a dominant mouse l11U[ation resulting in prcl11<lture ce ll 
death . NIII"re Celie! 1 :226-229, ·1992 
K~l\"akami Y, Etiy.\hu S, Dclg.\«(() C . Robbins P, Sakaguchi. K. Appella E, Vannelli J, 
Adem .. G, MHo T. Rosenberg S: Idcntitic;:ltion of a hUl11an mc.lanoma antigen 
recognized by tumor-infiltrating lymphocytes associa ted with ill 'Jjl'" tllmor 
rejection. Pro, Nll t! Aend Sci USA 91 :6458-6462, 1994 
Kim RY, W iscow G): The eDNA R.PEI and monoclonal antibody HMJ3-50 define 
gene products preferentially expressed In rctin:ll pigment epithelium . E:'J) E)fC Res 
55:657-662, 1992 
J(ob<lyashj T , Urabc K, Winder A,J imenez- Cervantes C, Imokawa G, 13rewingrol1 T, 
Solano F, Garcia-Bo rron JC, H earing VJ : Tyrosinase related protein 1 (TlUll) 
fUl1ctiOll S as: a DHICA oxidase in 1T1clanin biosynthesis. E'1\11BOj 13:5818-5825. 
1994 
Kroulnl'0uzos G, Urabe K, Kobayashi T, Sakai C . Hearing Vj: Functional analysis of 
the £1(11)' gene product (TR.P2) as dopacilrolllc talltomcrasc ilnd the effect of a 
point J1)ur:ttion OJ] hs catalytic function . .l3iochcm BiopIJys Res COIIIIIIIHl 202:1060-
1068, 1994 
Kwon I3S. Chint<1nwllcni C. Kozak CA, Copeland NG. Gilbert DJ.Jenkins N . B~lrton 
D. Francke U , Kobayashi Y , Kim 'K-K: A melanocyte-specific gene, pmcl 17 , 
maps near the sillier coat color IOCllS on mouse chromosome 10 and is in a syntcnic 
region on human chromosome 12. Proe Nm/ Aclltl Sci USA 88:9228 - 9232, 199·1 
Kwo n DS, HaJaban R, l{jm GS. Pomerantz 5, Hilq A: A mel:lI1ocytc-spccifi c eDNA 
clon c whose expression is inducible by MSH and IBMX. Mol iJiol Med 4:339-
35(.,1987 
}(",,'o J) ES, Hal:lban R, Ponnazhagan S, }(jill K-K. C hin tamaneni CD. Dennen 0 , 
Pickn rd itT: Mo use sil lier mutil tion is ca used by a sing le base illscrtion jn the 
putative cytoplasrnic domain of Pille! 17. Nllcide Ileitis Rl~S 23: t 54 -{58, 1995 
Kwon DS, Kim K-K. HaJ:,ban rt. Pickard RT: Characterization of mouse Pmcl17 gene 
alld 5ilv",· locus. P(~".e"l Cell Res 7:394-397,1994 
Kwt)n BS: Pi gmentation genes. tyros inase gene fhmily ilnd pme! '17 gene filllli ly.} fllllesl 
DCnI"'lol 100: 1345-'1405, 1993 
Lu D, Willard D, Patel IR, Kadwell S. Overton L, Kost T, Luther M, C hen W , 
Woychik RP. W ilkison WOo Cone R.D: Agouti protein is an antagonist of the 
mcJanocyrc-stimul.1ting hormone receptor. N afllre 371:799-802, 1994 
Miller DW , Safer P, Miller LK: An insect bacLlloviru, host-vector system for high-level 
cxprcs~iol'l of forei g n genes. In: Sctlow JR. Hollacndcr A (cds.). Cel/elie 
Fillgiueerill,.e. Plenum Publishing Corp. New York, J 986. pp 277-298 
Mochii M. Agata K. Eguchi G: Complete sequence and expression of a eDNA 
encoding a chicken '1'1 5-kDa TllclanOsolllai matrix prote in. J>~g", clll Cell Res 
4:41-47,1991 
Novikoff AB. Novikoff PM. Cleveland D. Q uintana N: Studies on l11icroperoxisomes 
V. Arc mi cro pcroxisornes ubiquitous hI mamnwl ian cell s? J /-lisllJcilem C }'wc:fWII/ 
21:737-755, 1973 
THE J OURNAL OF INVESTIGATIVE DERMATOLOGY 
Orlow SJ. Boissy RE. Mor:.m OJ, Pifko-Hirst S: Subcellula.r distributio n oftyrosi.llase. 
and tyrosinasc-related protein-l: impUcacions for melanosomnl biogcnesis. J 
l,,"cs( D l:.'rIIl (,tol 100:554-564, 1993a 
O rl ow SJ, Zhou B-K, Boissy R-E, Pifko-Hirst S: Identiftcation of a mammalian 
mclanosomalmatrix glycoprotein.) Ill vesl DcrlllllloIIOl:141-144. 1993b 
Orlow SJ , Z bou ll-K, C hakraborty AK, Drucker M, Pifko-Hirst 5, Pawelek )M: 
Higll-mo]ccuJar-w cight forms of ryrosinnse and the tyrosinase-related proteins: 
evidence for" melanogenic complex. ) 1111'"51 De"''''lol 103"1 %-201. 1994 
Quevedo W C Jr. Chase HB: An analys is of the I(!ht mutation o f coat colo r in mice.) 
NJ."7,ilOl 102:329-346,1958 
Quevedo we Jr. Fleischmann RD. Dyckman J: Premature loss of mclanocytes from 
hair follicle s of Ug/.1 (B
"
) and silver (5 i) mice . In : Seij i M (cd.). Piglllenl Cd/198l: 
PII('"Myp;c Exprcss;cHI ;'1 P(f:IIICI/( Cells. Proceedings of the Xlth International 
Pigment CeJ] Conference. Scndai, Japan. 1980. Un.iversity of Tokyo Press~ 
Tokyo, 1981, pp n7-1 83 
Schaumburg-Lever G, Metzler G, Kaiscrlillg E: Ultrastructural localization of 
I-lMB-45 binding sites.) C"/(III Patlwl 18:432-435, 199J 
Sil vers WK: T"e Co at Colors of Mic.e: A Nlodt'/ of 1\1{Wllllaliml GellC~ Aefiotl mill II/temelio'i. 
Springer, New York, 1979 
Taatjcs OJ, Arcndash-Dunmd B , von TlIrkovic..:h M, Trainer T: HM.B-45 antibody 
demonstrates melanosol)ll! specificity by irnmllnoelcctron microscopy. Arch 
1'1111101 LIIb Med 117:264-268 ,1993 
Tomiw Y . Shibahara S, Takeda A, Okinaga S. M:nsunaga, Tagami H: The 1ll0l10clonal 
antibodies TMH- I and TMH-2 specifica lly bind to a protein en coded at the 
ll1urine ii-locus. not to the authentic tyros inase encoded at the c.-locus. J JlI lICSt 
D"mllliol 96:500-504, 1991 
Vennegoor C. Hageman P, Van NoullllUs 1-1, Ruiter DJ , Calaf.1tJ , Ringens P) , Rumke 
P: A monoclonal antibody spec ific for cells of the melanocytc lineage. A lii) Patllol 
130:179 -1 92, 19S9 
Vijayasaradlti S, Xu Y, Bouchard B, Houghton AN: Intracellular sorting and t,1rgering 
of meJano.'iomaJ membrane proccins: identification of signals for sorting of the 
human Brow,,-locus protein, gp75.) Cell Bioi 130:807-820, 1995 
Winde r Aj, Wittbjcr A, Odh G, Rosengren E, RorslTlan H: The mouse bro",,, (b) locus 
protein functions as a dop:l chrome rnutomcr')SC. Pi,!!I1wllf Cell Rf~!i 7:304-3 10. 
1994 
Winder AJ, Wittbjer A, Rosengren E, Ror,l11an 1-1: The mouse Ioro",,, (b) locus protein 
has dop3chrortlc t'IUWmerase fl ctivity and j .~ located ill )ysQsom cs jn transfccted 
fibrob l.asts. J Cell 5ci 106'153-166, 1993 
Zhou B-K, Kobayashi T, DonatiCll I'D, Bennett DC, Hearing VJ, Orlow SJ : 
Identification of a I11clanoso,na) rnatrix protein encoded by the murine si (siJI,tr) 
locus using "organelle scanning." 1'''0' Nilll Aend Sci USA 91 :7076 -7080, 1994 
